Thursday, October 17, 2019
Time: 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Duration: 1 hour
Liquid-filled capsules (LFC) are the primary delivery platform for oral delivery of lipid formulations which includes both soft elastic capsules and liquid filled hard capsules. Liquid-in-bottle is another avenue for delivering lipid formulations. Proper deployment of these technologies can provide formulators with effective delivery platforms during early-phase development and commercial products.
Join industry experts for a discussion on strategies to develop lipid-based drug delivery systems (LBDDS) for oral delivery. The experts will present the fundamental principles, advantages and disadvantages of different dose forms for LBDDS and share considerations for selecting a suitable dose form for early phase development programs through commercialization.
Key learning objectives include:
- How and why LBDDS can support your bioavailability strategy
- The variety and different properties of LBDDS dosage forms
- How to navigate the dosage form development path from clinical phase to commercialization
David Fulper, Ph.D.
Director, Technology Support
Catalent Pharma Solutions
Kishor M. Wasan, R.Ph., Ph.D.
Fellow, AAPS Professor, College of Pharmacy and Nutrition
University of Saskatchewan